Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-10-000903
Filing Date
2010-11-12
Accepted
2010-11-12 12:13:11
Documents
4
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED SEPTEMBER 30, 2010 nymox6kq3100930.htm 6-K 5377
2 QUARTERLY REPORT FOR THE QUARTER ENDED SEPTEMBER 30, 2010 exhibit99-1.htm EX-99.1 325641
3 SOX SECTION 302 AND 906 CEO CERTIFICATIONS exhibit99-2.htm EX-99.2 8481
4 SOX SECTION 302 AND 906 CFO CERTIFICATIONS exhibit99-3.htm EX-99.3 8172
  Complete submission text file 0001176256-10-000903.txt   349136
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 101184633
SIC: 2835 In Vitro & In Vivo Diagnostic Substances